Comparative efficacy and tolerability among different selective serotonin re-uptake inhibitors and venlafaxine in a naturalistic setting

References

• Judd L L. Mood disorders in the general population represent an important and worldwide public health problem. Int Gin Psychopharmacol 1995; 10(suppl 4)5–10
   PubMedGoogle Scholar
• Sherwood N, Hindmarch I. A comparison of five commonly prescribed antidepressants with particular reference to their behavioural toxicity. Human Psychopharmacology 1993; 8: 417–422
   Web of Science ®Google Scholar
• Anderson M I, Tomenson B M. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8: 238–249
   PubMed Web of Science ®Google Scholar
• Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacol 1986; 90: 131–8
   PubMed Web of Science ®Google Scholar
• Fabre L F. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients. J Clin Psychiatry 1992; 53(suppl)40–43
   PubMedGoogle Scholar
• Kasper S, Lepine J P, Mendlewicz J, et al. Efficacy, safety and indications for tricyclic and the newer antidepressants. Depression 1995; 2: 127–37
   Google Scholar
• Kocsis J H, Zisook S, Davidson J, et al. Double-blind comparison of sertraline, imipramine and placebo in the treatment of dysthymia. Psychosocial outcomes. Am J Psychiatry 1997; 154: 390–5
   PubMed Web of Science ®Google Scholar
• Laakmann G, Blaschke D, Engel R, Schwarz A. Fluoxetine vs amitriptyline in the treatment of depressed Outpatients. Br J Psychiatry 1988; 153(suppl 3)64–68
   Google Scholar
• Möller H J, Fuger J, Kasper S. Efficacy of new generation antidepressants. Meta-analysis of imipramine controlled studies. Pharmacopsychiatria 1994; 27: 215–23
   Google Scholar
• Rudorfer M V, Potter W Z. Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the “newer” versus the “older” drugs. Drugs 1989; 37: 713–38
   PubMed Web of Science ®Google Scholar
• Schweizer E, Feighner J, Mandos L A, et al. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. J Clin Psychiatry 1994; 55: 104–8
   PubMed Web of Science ®Google Scholar
• Stark P, Hardison C D. A review of multicenter controlled studies of fluoxetine vs. Imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985; 46: 53–8
   PubMed Web of Science ®Google Scholar
• Bhaumik S, Collacott R A, Gandhi D, et al. A naturalistic study in the use of antidepressants in adults with learning disabilities and affective disorders. Human Psychopharmacology 1995; 10: 283–8
   Google Scholar
• Mendlewicz J. Pharmacologic profile and efficacy of venlafaxine. Int Clin Psychopharmacol 1995; 10(suppl 2)5–14
   PubMedGoogle Scholar
• Preskorn S H. Antidepressant drug selection: Criteria and options. J Clin Psychiatry 1994; 55(suppl A)6–22
   PubMedGoogle Scholar
• Clerc G E, Ruimy P, Verdeau J. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 1994; 9: 139–143
   PubMed Web of Science ®Google Scholar
• Danjou P, Hackett D. Safety and tolerance profile of venlafaxine. Int Clin Psychopharmacol 1995; 10(suppl 2)15–20
   PubMedGoogle Scholar
• Aguglia E, Casacchia M, Cassano G B, et al. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993; 8: 197–202
   PubMed Web of Science ®Google Scholar
• Ansseau M, Gabriels A, Loyens J, et al. A double-blind comparison of paroxetine and fluvoxamine in major depression. Eur Neuropsychopharmacol 1993; 3: 323–4
   Google Scholar
• De Wilde J, Spiers R, Mertens C, et al. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiatr Scand 1993; 87: 141–5
   PubMedGoogle Scholar
• Latimer P R, Ravindran A V, Bernatchez J P, et al. Sertraline versus fluoxetine treatment in major depression. Poster. Tenth Congress of World Psychiatric Association, Madrid 1996
   Google Scholar
• Patris M, Bouchard J M, Bougerol T, et al. Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharmacol 1996; 11: 129–136
   PubMedGoogle Scholar
• Hylan T R. Antidepressant use in clinical practice. Royal Society of Medicine (Roundtable series) 1998; 43: 11–16
   Google Scholar
• Hylan T R, Menades L, Crown W H, et al. Patterns of antidepressant use and their relation to clinical outcomes. J Affect Disorders, (in press).
   Google Scholar
• Katzelnick D J, Kobak K A, Jefferson J W, et al. Prescribing patterns of antidepressant medications for depression in a HMO. Formulary 1996; 31: 374–88
   Google Scholar
• Donoghue J M. Prescribing patterns of selective serotonin reuptake inhibitors in primary care: a naturalistic follow up study. J Serotonin Res 1996; 4: 267–70
   Google Scholar
• Mackay F J, Dunn N R, Wilton L V, et al. A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Safety 1997; 6: 235–46
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
   PubMed Web of Science ®Google Scholar
• Spielberger C D. State-Trait Anxiety. Inventory. Consulting Psychologists Press, Palo Alto, CA 1983
   Google Scholar
• Guy W. Assessment manual for psychopharmacology. US Department of Health, Education and Welfare Publication ADM 76–338. National Institute of Mental Health, Rockville, MD. 1976; 217–222
   Google Scholar
• Alonso M P, de Abajo F J, Martinez J J, et al. Evolución del consumo de antidepresivos en España. Impacto de los inhibidores selectivos de la recaptación de serotonina. Med Clin (Barcelona) 1997; 108: 161–6
   PubMedGoogle Scholar
• Campbell L K, Robison L M, Skaer T L, Sclar D A. Depression. Interventions and their effectiveness. Dis Manage Health Outcomes 1997; 2: 223–37
   Google Scholar
• Dierick M, Ravizza L, Realine R, Martin A. A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Prog Neuropsychopharmacol Biol Psychiatry 1996; 20: 57–71
   PubMed Web of Science ®Google Scholar
• Vanelle J M, Attar-Levy D, Poirier M F, et al. Controlled efficacy study of fluoxetine in dysthymia. Br J Psychiatry 1997; 170: 345–50
   PubMedGoogle Scholar
• Fisher S, Kent T A, Bryant S G. Postmarketing surveillance by patient self monitoring: preliminary data for sertralien versus fluoxetine. J Clin Psychiatry 1995; 56: 288–96
   PubMed Web of Science ®Google Scholar
• Statistical package for the social sciences. SPSS Windows 6.0. SPSS Inc., Chicago 1993
   Google Scholar